openPR Logo
Press release

Diabetes Therapeutics Market Report involving Key Players:AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A.

02-14-2020 08:45 PM CET | Health & Medicine

Press release from: Western Market Research

Diabetes Therapeutics Market Report involving Key

The global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at a CAGR of 16.0% from 2017 to 2023. Diabetes therapeutics are drugs used by diabetic patients to restore the blood glucose metabolism to a normal state.

Ask for a free Sample-[Injectabl#sample

The factors that drive the global diabetes therapeutics market include rise in geriatric population, increase in prevalence of diabetes worldwide, sedentary lifestyle of people, development of affordable & effective diabetes therapeutics, growth in awareness among people about self-management of diabetes, and support from the government However, side effects of diabetic drugs and stringent approval process for the same restrict the market growth. Moreover, surge in awareness about diabetes care and market potential in developing regions are expected to provide numerous opportunities for market growth.

The global diabetes therapeutics market is segmented on the basis of product and region. Based on product, it is bifurcated into injectable and oral-antidiabetic drugs (OAD). Injectable are further categorized into insulin, glucagon-like peptide-1 (GLP-1) receptor agonists, and amylinomimetic drug. Oral-antidiabetic drugs (OAD) segment is further divided into biguanides, sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, dipeptidyl peptidase IV (DPP-4) inhibitors, meglitinides, and sodium-glucose cotransporter-2 (SGLT2) inhibitors. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).


The study provides an in-depth analysis of the market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
Key market players are profiled and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.

Click and ask for instant 30% discount @ WMR -[Injectabl#inquiry



Glucagon-like Peptide-1 (GLP-1) Receptor Agonists/Incretin Mimetics
Amylin Analogue/Amylinomimetic Drugs
Oral-antidiabetic Drugs (OAD)
Alpha-glucosidase Inhibitors
Dipeptidyl Peptidase IV (DPP-4) Inhibitors/Gliptins
Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors/Gliflozins


North America
Rest of Europe
South Korea
Rest of Asia-Pacific
Saudi Arabia
South Africa
Rest of LAMEA

Buy this Report Now -


AstraZeneca plc
Boehringer Ingelheim GmbH
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Sanofi S.A.
Takeda Pharmaceutical Company Limited

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Astellas Pharma Inc.
Biocon Limited
Diasome Pharmaceuticals, Inc.
Generex Biotechnology Corp.
MannKind Corporation
Pfizer Inc.

Read in Details click on below -[Injectabl

For More info.

Kritarth Arun (Marketing & Sales)
Office No.6, CN7, Survey No. 94-95
Pune, Maharashtra, India.
Phone No (US)+1 (650) 741-1345
Phone No (IN) +91 7757044254


Western Market Research is a global player, among top market research companies, with niche in intelligent industry analysis, business report, syndicate, comprehensive and secondary research report having in-depth data analysis based on history trends and forecast, segmentation, major players, market size and market share. Our research firm comprises of analysts with insights on market overview providing business consulting services resulting in breakthrough primary and secondary market research reports.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Therapeutics Market Report involving Key Players:AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk, Sanofi S.A. here

News-ID: 1933318 • Views: 361

More Releases from Western Market Research

Membership Software Market Report involving Key Players: EveryAction,GrowthZone, …
Membership Software Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Membership Software industry with a focus on the Chinese market. The report provides key statistics on the market status of the Membership Software manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of
Pharmaceutical Logistics Market Report involving Key Players: FedEx, Deutsche Po …
What is Pharmaceutical Logistics? Pharmaceutical Logistics is defined as the logistics of pharmaceuticals, medical and surgical supplies, medical devices and equipment, and other products that are required for supporting doctors, nurses, and other health and dental care providers. Pharmaceutical logistics play an important role in maintaining and improving health and lives of the plays a crucial part of healthcare system. In order to drive costs out of the health-care sector,
Public Safety and Security Market Report involving Key Players: NEC Corporation, …
GLOBAL PUBLIC SAFETY AND SECURITY MARKET SIZE AND FORECAST TO 2025 Global Public Safety and Security Market Analysis According to Verified Market Research, The Global Public Safety and Security Market was valued at USD 307.8 Billion in 2017 and is projected to reach USD 767.6 Billion by 2025, growing at a CAGR of 14.3% from 2018 to 2025. Ask for a free Sample- What is Public Safety and Security? Public security and safety
Alarm Monitoring Market Report involving Key Players: Honeywell International, U …
GLOBAL ALARM MONITORING MARKET SIZE AND FORECAST TO 2025 Global Alarm Monitoring Market Analysis According to Verified Market Research, the global Alarm Monitoring market was valued at USD 42.20 Billion in 2017 and is projected to reach USD 62.47 Billion by 2025, growing at a CAGR of 5.0% % from 2018 to 2025. Ask for a free Sample- What is Global Alarm Monitoring? Alarm monitoring is process of communicating quickly between

All 5 Releases

More Releases for Diabetes

Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
27th European Diabetes Congress
We would like to invite your team as a Speakers/Delegates. On behalf of Organizing Committee, we take this opportunity in extending a warm and cordial welcome to you to be part of “27th European Diabetes Congress”, held conjointly with multifarious scientific associations, eminent researchers and scholars from all around the globe during June 20-21, 2018 at Rome, Italy. It is an immense pleasure and privilege having you here with us
Global Diabetes Management Devices Market
ReportsWorldwide has announced the addition of a new report title Global Diabetes Management Devices Market to its growing collection of premium market research reports. The global market for diabetes management devices is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area. The report provides the following useful information: • diabetes overview • key statistics on diabetes prevalence in major regions in the world • medical device product
Non Invasive Diabetes Therapy Market
The role of non-invasive therapy for diabetes market has been on a positive growth path in healthcare industry since 2014. Though the non-invasive therapy concept was brought way back in 1980, the market has not gained much attention leading to development of fewer such devices. DexCom's seven system and Medtronic's Guardian real-time glucose monitoring system are two such products developed and marketed worldwide. The influx of non-invasive therapy has reinforced
Diabetes Gastroparesis Market grows with rising prevalence of diabetes
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the